Eli Lilly strikes deal with EU over Covid-19 antibody treatment
The pharmaceutical company will provide another 220,000 antibody doses for the treatment of Covid-19 patients.
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
Eli Lilly has reached a procurement agreement with the EU to supply 220,00 doses of the US-based pharmaceutical company's antibody treatment for patients with Covid-19.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly to raise millions for green initiatives
For subscribers
.jpg)
.jpg&w=384&q=75)
